• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CellCyte Genetics Corp

+ Add to Watchlist


0.003 EUR 0.001 50.00%

As of 02:16:02 ET on 01/27/2015.

Snapshot for CellCyte Genetics Corp (LK6)

Open: 0.002 Day's Range: 0.002 - 0.003 Volume: 0
Previous Close: 0.002 52wk Range: 0.001 - 0.012 1-Yr Rtn: -57.14%

Stock Chart for LK6

No chart data available.
  • LK6:GR 0.003
  • 1D
  • 1M
  • 1Y
Interactive LK6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LK6

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.25
Shares Outstanding (M) 82.33
30 Day Average Volume 3,284
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LK6

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LK6

CellCyte Genetics Corporation is a biotechnology company that is developing stem cell therapeutic products. The Company is developing clinical-stage therapeutic agents and treatments for oncology, diabetes, heart, liver, lung and kidney diseases as well as for stem cell bone marrow and organ transplants.

John M Fluke JrChairmanDouglas Pat Cerretti "Doug"President
Randy A LieberPrincipal Accounting Officer
More Company Profile & Key Executives for LK6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil